Frontiers in Cellular Neuroscience, 2024 · DOI: 10.3389/fncel.2024.1404463 · Published: May 15, 2024
Spinal cord injury (SCI) can cause loss of sensory and motor function below the level of injury, posing a serious threat to human health and quality of life. One significant characteristic feature of pathological changes following injury in the nervous system is demyelination, which partially contributes to the long-term deficits in neural function after injury. The remyelination in the central nervous system (CNS) is mainly mediated by oligodendrocyte progenitor cells (OPCs).
miRNAs regulating OPC function offer a potential therapeutic avenue for SCI treatment by enhancing remyelination.
Efficient delivery methods for miRNA-based therapies are needed to improve stability and tissue penetration in vivo.
Promoting remyelination through miRNA modulation can lead to improved functional recovery after SCI.